The studies demonstrated similar changes in both men and women
Arun Gulani, an eye surgeon at the Gulani Vision Institute, who explained that there is no established treatment protocol for NAION, which is considered irreversible. However, Gulani, who was also not involved in the study, told us that Experimental treatments are being evaluated nationally and worldwide. The lead author of the recent study was Joseph Rizzo, MD, director of the Neuro-Ophthalmology Service at Mass Eye and Ear in Boston, MA
He, F., Chen, W., Xu, W., Liu, D., Xiao, Z., Tang, Y., Lin, Z., Liao, Y., Bin, J., Chen, G., & Chen, Y
& Morris, T
Although its not yet confirmed if this risk applies to humans, individuals with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 should avoid using tirzepatide